Dorota Waclawczyk

Dorota Waclawczyk

Auto-generated profile, based on publicly available information

Dorota Waclawczyk

IDRO B.V., Bd de Waterloo 65, 1000 Bruxelles, Belgium

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Verified
Journal Article
Open access
DWDorota Waclawczyk
Dorota Waclawczyk
LSLeili Soo
Leili Soo
RRRoberto Morollon Ruiz
Roberto Morollon Ruiz
ACAvi Caspi
Avi Caspi
EFEduardo Buglioni Fernandez
Eduardo Buglioni Fernandez
Cortical prostheses aim to provide artificial vision to blind individuals by electrically stimulating the occipital cortex to induce visual sensations called phosphenes. Previous research demonstrates that phosphene location is influenced by gaze position, despite fixed electrode placement in the occipital cortex. However, for patients without eyes, it is unclear whether intended eye movements can still modulate phosphene location and, if they do, whether these movements can be accurately recorded and incorporated into prosthetic control algorithms. As part of a clinical trial using intracortical electrical stimulation via a Utah array implanted into the early occipital cortex as a visual prosthesis interface, we had the opportunity to study a patient who lost both eyes due to traumatic injury. This patient currently wears cosmetic eyes. We initially investigated whether intended eye movements modulated the perceived location of phosphenes, and upon confirming their influence, we explored the possibilities for tracking these movements. We recorded the intended eye movements in four cardinal directions using electrooculogram (EOG) and a video-based eye-tracking system. These recordings were then compared with data obtained from a sighted control participant. Our results demonstrated the feasibility of tracking cosmetic eye movements and revealed a significant correlation between eye position and perceived phosphene locations. Then, we conducted behavioral search experiments in which the patient used intended eye movements to locate target objects present on a screen. The results show that the patient’s ability to accurately identify object locations using eye movements as recorded in real time with a video-based tracker on a cosmetic eye. These findings highlight the importance of incorporating gaze position into future visual prostheses, even in patients without eyes.

7 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
LSLeili Soo
Leili Soo
ADAlfonso Rodil Doblado
Alfonso Rodil Doblado
FGFabrizio Grani
Fabrizio Grani
RPRocio Lopez Peco
Rocio Lopez Peco
AVAdrián Villamarin-Ortiz
Adrián Villamarin-Ortiz
EFEduardo Buglioni Fernandez
Eduardo Buglioni Fernandez
Purpose: Electrical stimulation of the occipital cortex evokes visual percepts known as phosphenes. To date, most human studies have examined phosphenes elicited by large surface or depth electrodes. These differ considerably from the small penetrating intracortical microelectrodes capable of stimulating highly localized cortical populations that are the basis of current next-generation devices. Here, we provide a detailed characterization of phosphenes evoked by such intracortical microelectrodes. Methods: As part of the CORTIVIS clinical trial, a Utah Electrode Array with 100 penetrating electrodes was implanted in the early visual cortex of four blind volunteers. Participants completed drawing and description tasks in response to single-electrode stimulation. Two participants also performed forced-choice tasks to determine whether phosphenes elicited by different electrodes could be reliably discriminated. Results: Single-electrode stimulation reliably evoked phosphenes in all participants. Most percepts appeared in the contralateral visual field, although two participants reported near-midline ipsilateral percepts. Phosphenes ranged from simple dots to elongated, textured, circular, or otherwise idiosyncratic forms. One participant reported distinguishable phosphene colors, which depended on electrode and amplitude structure and varied across sessions. The two participants tested on forced-choice discrimination could successfully identify electrode-specific phosphenes across multiple sessions. Conclusions: Intracortical microstimulation of the human visual cortex produces phosphenes with diverse, electrode-specific appearances that are recognizable across repeated trials. These findings indicate that penetrating microelectrodes often evoke more structured percepts than simple points or blobs, providing foundational evidence that electrode-specific encoding strategies will be necessary in future visual prosthetic devices.

22 September 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
ESEvangelia Salmatani
Evangelia Salmatani
GDGeorge Dimitriou
George Dimitriou
George E. DafoulasGeorge E. Dafoulas
George E. Dafoulas
DKDimitrios G. Katehakis
Dimitrios G. Katehakis
AKApostolia Karabatea
Apostolia Karabatea
AKAngelina Kouroubali
Angelina Kouroubali
Background/Objectives: Remote patient monitoring (RPM) is recognized as a key component of health system transformation in Europe, in the context of vulnerable populations. However, its large-scale adoption remains uneven across countries. The research explored how technical infrastructure, governance and regulation, interoperability, and ecosystem readiness influence RPM adoption and scale-up in seven European country contexts. Methods: An exploratory qualitative cross-country study combined targeted desk research with semi-structured interviews conducted between February and March 2025. The interviews were recorded with consent, manually transcribed, anonymized, and analyzed using a manual hybrid deductive–inductive thematic approach. The desk research provided contextual information and remained distinct from the interview-derived findings. Results: The analysis was organized around four higher-order themes including digital infrastructure and RPM technologies; governance and regulatory frameworks; interoperability and health-data integration; implementation barriers and ecosystem readiness. RPM technologies were present in all examined contexts, but their integration into routine care remained uneven. Recurrent barriers included fragmented reimbursement pathways, uneven operationalization of EU rules, limited interoperability, weak integration with Electronic Health Records and clinical workflows, digital-literacy gaps, and insufficient mechanisms for progressing from pilots to sustained implementation. Conclusions: Stakeholders more frequently identified system-level implementation conditions, including governance, reimbursement, interoperability, and workforce readiness, than technology availability alone as barriers to RPM scale-up. The European Health Data Space may provide an enabling framework, but its impact will depend on national and regional implementation capacity.